The period prevalence of double expression diffuse large B-cell lymphoma patients and its associated risk factors and treatment response in Hospital Universiti Sains Malaysia from 2004 to 2015
Background and Objective: Diffuse Large B-Cell Lymphoma (DLBCL) is a heterogeneous and complex disease. Its protein expression of MYC and BCL2 and/or BLC6 (Double Expression) is associated with poor response to standard treatment, thus poor prognosis. The aim is to determine the period prevalence o...
Main Author: | Yong, Teh Chee |
---|---|
Format: | Thesis |
Language: | English |
Published: |
2017
|
Subjects: | |
Online Access: | http://eprints.usm.my/45621/1/Dr.%20Teh%20Chee%20Yong-24%20pages.pdf |
Similar Items
-
The immunohistochemical studies of double or triple protein lymphoma in diffuse large B-cell lymphoma and their correlation with clinicopathological parameters
by: Wahab, Wan Nor Najmiyah Wan Abdul
Published: (2017) -
Immunohistochemical expression of hedgehog proteins in diffuse large B-cell lymphoma
by: Azman, Siti Nur Lina
Published: (2016) -
Expression profile of HIP1R in B-cell subsets and in silico prediction of its functions in diffuse large B-cell lymphoma
by: Keng, Wong Kah
Published: (2018) -
Frequency of antigens expression and epstein-barr virus on diffuse large b-cell lymphoma
by: Lee, K.K., et al.
Published: (2007) -
Identification of MYC/BCL2 double-expressers lymphomas in diffuse large B cell lymphoma patients and association with their prognostic parameters and survival rates: a single centre experience
by: Ahmad, Aliza, et al.
Published: (2022)